PCFA Funded trial: ProPSMA Pet/CT (Prof Declan Murphy & Prof Michael Hofman).

Funded research - ProPSMA PET/CT: A Prostate Cancer Support Group Education Webinar.Подробнее

Should PSMA PETCT replace conventional imaging Assoc Prof Declan Murphy, Peter MacCallum Cancer CentПодробнее

#EAU19 Focal Therapy thematic session | Prof Declan MurphyПодробнее

ANZSNM ArtNet Talk by Professor Michael Hofman #ProsTICПодробнее

Welcome to the Wild West: The impact of FDA approval of PSMA PET/CT. ASCO GU 21 talkПодробнее

Beyond wizardry creating high level evidence for PSMA PET Imaging and Theranostics Michael Hofman, PПодробнее

ProPSMA Randomised Study of Ga-68 PSMA PET/CT at EAU 2020Подробнее

#EAU21 Plenary | Role of PSMA PET/CT for de novo vs recurrent diseaseПодробнее

PCFA Funded trial: ProPSMA Pet/CT (Prof Declan Murphy & Prof Michael Hofman).Подробнее

Team Greg Racing GJ#61 - PCFAПодробнее

Validation of PSMA-PET to the most used nomograms for pelvic lymph-node metastases predictionПодробнее

Peter Mac's Prof Michael Hofman on The House of WellnessПодробнее

Next Generation PSMA: PCF ProsTIC Global Knowledge Exchange WebinarПодробнее

Prof Michael Hofman talks to Nine News about the TherpaP trialПодробнее

GU Cast | PSMA PET/CT prior to biopsy? The PRIMARY StudyПодробнее

The Canadian PET phantom for prostate oncology C3PO – a multimodality imaging phantom for 18F PSMA hПодробнее

Associate Professor Declan Murphy on ABC News, Tuesday 17 FebruaryПодробнее

TheraP (ANZUP 1603) Study Deep Dive: Global Knowledge Exchange WebinarПодробнее

Quantitative PSMA PET/CT in the ProPSMA StudyПодробнее

ProsTIC PCF Global Exchange Webinar: VISION trialПодробнее